about
Non-peptide opioid receptor ligands - recent advances. Part I - agonists.Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.Non-peptide opioid receptor ligands - recent advances. Part II - antagonists.Molecular structure of ionotropic glutamate receptors.Click chemistry for drug development and diverse chemical-biology applications.Isothermal titration calorimetry in membrane protein research.Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors.Discovery of nitroaryl urea derivatives with antiproliferative properties.Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptor.Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors.Structural and molecular docking studies of 4-benzyl-3-[(1-methylpyrrol- 2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with anticancer activity.Determination of affinity and efficacy of acetylcholinesterase inhibitors using isothermal titration calorimetry.The pseudo-Michael reaction of 1-aryl-4,5-dihydro-1H-imidazol-2-amines with ethyl ethoxymethylenecyanoacetate.Synthesis, antiviral activity and structure-activity relationship of 1-(1-aryl-4,5-dihydro-1H-imidazoline)-3-chlorosulfonylureas and products of their cyclization.Microwave-assisted preparation, structural characterization, lipophilicity, and anti-cancer assay of some hydroxycoumarin derivatives.Synthesis, central nervous system activity and structure-activity relationships of novel 1-(1-Alkyl-4-aryl-4,5-dihydro-1H-imidazo)-3-substituted urea derivatives.6-(2-Chloro-benz-yl)-1-(4-chloro-phen-yl)-7-hy-droxy-2,3-dihydro-1H-imidazo[1,2-a]pyrimidin-5-one.Synthesis, central nervous system activity, and structure-activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones.1-(3-Chloro-phen-yl)-3-(1-p-tolyl-imidazolidin-2-yl-idene)ureaSynthesis and antiviral activity of 1-(1,3-disubstitutedimidazolidyn-2-ylidene)-3-ethoxycarbonylmethylurea derivatives.Structure-based virtual screening for novel inhibitors of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase.Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor.Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors.Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine. Part 1. Synthesis and pharmacological activity of chain derivatives of 1-aryl-2-iminoimidazolidine containing urea moiety.Comparison of retention of aromatic hydrocarbons with polar groups in binary reversed-phase high-performance liquid chromatography systems.Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine: part 2. Synthesis and pharmacological activity of 1,6-diaryl-5,7(1H)dioxo-2,3-dihydroimidazo[1,2-a][1,3,5]triazines.Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics.Interplay between Two Allosteric Sites and Their Influence on Agonist Binding in Human μ Opioid Receptor.Modeling of glutamate GluR6 receptor and its interactions with novel noncompetitive antagonists.Theoretical studies on the structure and symmetry of the transmembrane region of glutamatergic GluR5 receptor.Application of Raman spectroscopy for direct analysis of Carlina acanthifolia subsp. utzka root essential oil.Electron ionization mass spectra of aryl- and benzyl-substituted 2,3-dihydroimidazo[1,2-a]pyrimidine-5,7(1H,6H)-diones.Molecular mechanisms of allosteric probe dependence in μ opioid receptor.Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.Synthesis, Structural Studies and Molecular Modelling of a Novel Imidazoline Derivative with Antifungal Activity.Synthesis, central nervous system activity and structure-activity relationship of N-substituted derivatives of 1-arylimidazolidyn-2-ylideneurea and products of their cyclization.Synthesis, pharmacological activity and molecular modeling of 1-aryl-7- hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones and their 6-substituted derivatives.Autophagic cell death and premature senescence: New mechanism of 5-fluorouracil and sulforaphane synergistic anticancer effect in MDA-MB-231 triple negative breast cancer cell line.Nuclear estrogen receptors co-activation mechanisms.Protein-Protein Docking in Drug Design and Discovery.
P50
Q30842038-670490D6-C93E-4A46-A4FD-3FFBDA9775A2Q33395465-46081A85-424F-4D91-806F-D99CBE793EE9Q34780042-DE20C063-9DFB-4EA4-B9B0-EE0299288DDDQ37758865-124D309A-42F9-4AF5-8BD2-6B757AC228B9Q38093289-C336F77C-20E6-4D0B-A586-82977BD8B6ACQ38152014-3AE47C71-C851-43B5-966A-BA8DD4915135Q38675922-CAE3A5AF-263E-43F3-B0A5-1C1D3607DF38Q38859827-80BF17DF-EFF8-4965-8198-C973FFA71E25Q38933112-2BB29D99-6428-4FB7-847B-CEB1748D251FQ39152860-D719F820-FB71-49DD-89F9-26F9543A57DEQ39323592-24CD2C54-4967-497A-B08F-E58E823FCCEAQ40299655-F3C994AC-D8EE-426B-80C3-28742B92D916Q40745786-3A080D1B-9190-4060-A6E6-120F776E6B11Q41089151-842E69E2-5B7E-4541-86CE-23AE254865CFQ41265865-7F882D75-244B-4117-BBE7-A57AFD9D0F59Q41325311-7B073635-E246-463C-B35E-DF1662EEE9A6Q41453235-3F6F7E82-255E-4B35-A63D-6B77F10F05F4Q41828638-6B249B3C-0D8E-4A54-B84F-D4BF8D8F63C9Q42059090-4756BDA9-56F7-4CCF-AE2E-788C33905730Q42153196-024446EA-4E96-4F37-B6AA-52974C03E314Q42992194-5EFA8365-DF00-4193-9D14-0331E938B7D4Q43106747-ECADD04D-D073-440F-BDC9-0E1F079C0739Q43612396-268020B4-3819-48FB-8DDE-7478269671A2Q43819062-AC626929-C387-4402-B975-AF103BC230FDQ43908879-F2FBF17F-AA33-46F3-96AB-1D3422DDC838Q44154675-0927E23F-8F52-4208-9715-A946903CC802Q44333203-B96F8C5F-30BD-4A4A-9A74-3E53D0CC0965Q44335246-7523413C-59CD-4464-BB3F-5B491E8E5CE8Q44947230-F4E66A27-8822-4403-BFAC-0E4DF81DD1D2Q45342056-A5C61D6E-8E64-4BD0-A6F8-92F5F341C2CDQ46331606-4E9A3B3D-4F2E-430E-8DD7-EED103B148FAQ46917465-CC5FD3F6-E52D-4588-A7AE-F83D1D0AD1F6Q47293279-1EFCA94C-C8C2-488E-B2BC-2E84E340D61DQ47348671-9A4D1469-6F39-4AA7-9A6B-972AACBA820AQ47985762-AB3F321A-3EFE-4127-8A8A-30F5BFE8CD66Q48335299-C13A7DE6-6E2E-4C4F-88FB-200DBE866E4CQ48837647-4B98653A-41EA-47B6-ADD1-1FA0ED5DB608Q50148124-F740EA53-38D7-420E-9691-2BDADA39F897Q51013647-D2BBAFD1-178A-4A9C-BA52-68606D97E3E0Q52338319-DA4A5BEE-6738-4BBB-951B-A008105B2D37
P50
description
researcher ORCID ID = 0000-0002-2373-9479
@en
wetenschapper
@nl
name
Dariusz Matosiuk
@ast
Dariusz Matosiuk
@en
Dariusz Matosiuk
@es
Dariusz Matosiuk
@nl
Dariusz Matosiuk
@pl
type
label
Dariusz Matosiuk
@ast
Dariusz Matosiuk
@en
Dariusz Matosiuk
@es
Dariusz Matosiuk
@nl
Dariusz Matosiuk
@pl
prefLabel
Dariusz Matosiuk
@ast
Dariusz Matosiuk
@en
Dariusz Matosiuk
@es
Dariusz Matosiuk
@nl
Dariusz Matosiuk
@pl
P1153
6603687876
P31
P3124
P496
0000-0002-2373-9479